Contract 36C26224P0011
Cytopath Biopsy Lab Inc · Department Of Veterans Affairs · October 1, 2025
Cytopath Biopsy Lab Inc was awarded a federal contract by Department Of Veterans Affairs on October 1, 2025 for $510,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Los Angeles, CA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 12, 2025. If all options are exercised, the contract could reach $2.31 million.
Contract details
- PIID
- 36C26224P0011
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Reference Laboratory Testing
- Place of performance
- Los Angeles, CA
- First action
- October 1, 2025
- Latest action
- November 12, 2025
Description
THYROSEQ MOLECULAR TEST
Modification timeline
-
November 12, 2025Mod P00003 · Funding Only Action$1.41M
-
October 1, 2025Mod P00002 · Exercise An Option$1.35M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Abbott Laboratories Inc. | Department Of Veterans Affairs | April 1, 2026 | $1.56M |
| Bio Rad Laboratories Inc | Department Of Veterans Affairs | April 1, 2026 | $189.7K |
| Roche Diagnostics Corporation | Department Of Veterans Affairs | April 1, 2026 | $735.4K |
| Ortho-Clinical Diagnostics, Inc | Department Of Veterans Affairs | April 1, 2026 | $221.9K |
| Werfen USA Llc | Department Of Veterans Affairs | March 31, 2026 | $178.1K |
| Veterans Healthcare Supply Solutions, Inc | Department Of Veterans Affairs | March 31, 2026 | $176.8K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26224P0011?
Contract 36C26224P0011 is a federal contract awarded to Cytopath Biopsy Lab Inc by Department Of Veterans Affairs on October 1, 2025 for $510,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36C26224P0011?
Cytopath Biopsy Lab Inc won contract 36C26224P0011 from Department Of Veterans Affairs.
How much is contract 36C26224P0011 worth?
Contract 36C26224P0011 has obligated $510,000 to date, with a total potential value of $2.31 million if all options are exercised.